Diener H-C, Katsarava Z, Limmroth V
Universitätsklinik für Neurologie und Westdeutsches Kopfschmerzzentrum, Universitätsklinikum Essen, Hufelandstrasse 55, 45147 Essen.
Ophthalmologe. 2008 May;105(5):501-8; quiz 509-10. doi: 10.1007/s00347-008-1747-6.
Headaches are one of the most common disorders and symptoms in daily medical practice. The prevalence of migraine is 8% in men and 12-15% in women. Dramatic progress in the areas of epidemiology, pathophysiology, and acute and preventive therapy of migraine has been made over the past 100 years, with triptans being the breakthrough for treating acute migraine attacks. Beta blockers, calcium antagonists, and neuromodulators are available for preventive migraine therapy. Nonpharmacologic treatment also plays an important role in migraine prevention. New medical care structures such as integrated headache care provide better support for patients with migraine, particularly those with chronic migraine.
头痛是日常医疗实践中最常见的病症和症状之一。偏头痛在男性中的患病率为8%，在女性中为12% - 15%。在过去100年里，偏头痛的流行病学、病理生理学以及急性和预防性治疗领域取得了显著进展，曲坦类药物是治疗急性偏头痛发作的突破。β受体阻滞剂、钙拮抗剂和神经调节剂可用于偏头痛的预防性治疗。非药物治疗在偏头痛预防中也起着重要作用。诸如综合头痛护理等新的医疗保健结构为偏头痛患者，尤其是慢性偏头痛患者提供了更好的支持。
